MedPath

Unbranded

Brand Name: Unbranded

Generic Name: Brimonidine Tartrate

Active
Registration Number

DR-XY34076

Dosage Form

Sterile Ophthalmic Solution

Issuance Date

February 20, 2024

Expiry Date

December 26, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2 mg/mL (0.2% w/v)
Packaging5 mL in white opaque LDPE plastic droptainer bottle with tip, and with purple polypropylene cap (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiglaucoma and Miotic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Brimonidine TartrateActive
Monograph: Brimonidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform